The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $438,509 in first-year total cost, median $219,255.
Most frequent study sections
- Special Emphasis Panel[ZDA1 GXM-A (17)]2
Most frequent institutions
- PEAR THERAPEUTICS, INC.1
- TRANSCENDENT INTERNATIONAL, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Removing implementation obstacles and tailoring reward-based technology programs to patient psychographic characteristics to sustainably increase adherence to substance use disorder pharmacotherapies1R43DA049495-01 | TAN, WILLIAM Z | TRANSCENDENT INTERNATIONAL, LLC, NY | $223,676 | ZDA1 |
| 2019 | A Prescription Digital Therapeutic to Promote Adherence to Buprenorphine Pharmacotherapy for Patients with Opioid Use Disorder1R44DA049493-01 | LUDERER, HILARY F | PEAR THERAPEUTICS, INC., MA | $214,833 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.